Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: No Mention of TPL

The last PR that I am aware of where TPL was mentioned as a co-owner was on 2-16-11 when there was a PR about the 890 and 749

The last license announcement where TPL was mentioned as a co-owner was on 5-23-11 when Stryker was signed.

It would appear that since the settlement, PTSC is not required to mention TPL as a co-owner. Perhaps the BoD will address this at the SHAM

Share
New Message
Please login to post a reply